3′-唾液酸-Lewis-X 四糖 CAS 98603-84-0

3'-SLeX 3'-Sialyl-Lewis X 3'-Sialyl-Lewis-X tetrasaccharide 98603-84-0 D-Glucose, O-(N-acetyl-a-neuraminosyl)-(2>3)-O-b-D-galactopyranosyl-(1>4)-O-[6-deoxy-a-L-galactopyranosyl-(1>3)]-2-(acetylamino)-2-deoxy- (9CI) D-glucose, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2>3)-O-beta-D-galactopyranosyl-(1>4)-O-[6-deoxy-alpha-L-galactopyranosyl-(1>3)]-2-(acetylamino)-2-deoxy- SLex SSEA 1 Sialyl Lex tri Sialyl-Lewis X a-NeuNAc-(2>3)-b-D-Gal-(1>4)(a-L-Fuc-[1>3])-D-GlcNAc

纯度 97%+现货药物标准品
CAS 号98603-84-0
分子式C31H52N2O23
分子量820.74 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

3′-唾液酸-Lewis-X 四糖 3'-SLeX
3'-Sialyl-Lewis X
3'-Sialyl-Lewis-X tetrasaccharide
98603-84-0
D-Glucose, O-(N-acetyl-a-neuraminosyl)-(2>3)-O-b-D-galactopyranosyl-(1>4)-O-[6-deoxy-a-L-galactopyranosyl-(1>3)]-2-(acetylamino)-2-deoxy- (9CI)
D-glucose, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2>3)-O-beta-D-galactopyranosyl-(1>4)-O-[6-deoxy-alpha-L-galactopyranosyl-(1>3)]-2-(acetylamino)-2-deoxy-
SLex
SSEA 1
Sialyl Lex tri
Sialyl-Lewis X
a-NeuNAc-(2>3)-b-D-Gal-(1>4)(a-L-Fuc-[1>3])-D-GlcNAc CAS 98603-84-0 结构式 Chemical Structure

产品介绍 Description

CAS 98603-84-0 对应的3′-唾液酸-Lewis-X 四糖(3'-SLeX 3'-Sialyl-Lewis X 3'-Sialyl-Lewis-X tetrasaccharide 98603-84-0 D-Glucose, O-(N-acetyl-a-neuraminosyl)-(2>3)-O-b-D-galactopyranosyl-(1>4)-O-[6-deoxy-a-L-galactopyranosyl-(1>3)]-2-(acetylamino)-2-deoxy- (9CI) D-glucose, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2>3)-O-beta-D-galactopyranosyl-(1>4)-O-[6-deoxy-alpha-L-galactopyranosyl-(1>3)]-2-(acetylamino)-2-deoxy- SLex SSEA 1 Sialyl Lex tri Sialyl-Lewis X a-NeuNAc-(2>3)-b-D-Gal-(1>4)(a-L-Fuc-[1>3])-D-GlcNAc)为 CATO 佳途药物标准品产品线成员。分子式 C31H52N2O23,分子量 820.74。纯度 97%+。所有批次均经 HPLC/NMR 等多项检测确认,质量稳定可溯源。

在现行药典和法规框架下,药物标准品的合规要求中明确涉及对包括3′-唾液酸-Lewis-X 四糖在内的目标物的控制。 化学式为 C31H52N2O23 的3′-唾液酸-Lewis-X 四糖(3'-SLeX 3'-Sialyl-Lewis X 3'-Sialyl-Lewis-X tetrasaccharide 98603-84-0 D-Glucose, O-(N-acetyl-a-neuraminosyl)-(2>3)-O-b-D-galactopyranosyl-(1>4)-O-6-deoxy-a-L-galactopyranosyl-(1>3)-2-(acetylamino)-2-deoxy- (9CI) D-glucose, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2>3)-O-beta-D-galactopyranosyl-(1>4)-O-6-deoxy-alpha-L-galactopyranosyl-(1>3)-2-(acetylamino)-2-deox

应用场景:从实际应用出发,3′-唾液酸-Lewis-X 四糖(CAS 98603-84-0)在化学分析中作为关键的基准对照物质。 推荐以3′-唾液酸-Lewis-X 四糖配制标准系列工作溶液,用于建立标准曲线实现外标法定量。 建议使用甲醇/乙腈(1:1)为溶剂配制储备溶液,根据检测灵敏度需求逐级稀释。 使用建议: - 称量前将样品在干燥器内平衡至室温(约30分钟); - 储备溶液建议用甲醇/乙腈(1:1)配制,于阴凉处(≤25°C)保存,避光,密封防潮条件下储存; - 低浓度工作液(<10 μg/mL)建议当天配制使用,不宜长期存放; - 开启安瓿瓶/西林瓶后应在干燥环境下尽快使用,防止吸潮

理化性质 Physical & Chemical Properties

中文名称3′-唾液酸-Lewis-X 四糖
分子式C31H52N2O23
分子量820.74 g/mol
外观形态类白色至淡黄色无定形粉末
纯度97%+
储存条件阴凉处(≤25°C)保存,避光,密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)7.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)1985年
含氮原子数2

相关专利 Related Patents

  1. 发明人何建平,陈志强,黄志刚. "一种3′-唾液酸-Lewis-X 四糖的合成方法" [P]. 中国发明专利, 专利号 CN 113659138 B, 授权公告日 2025-05-02.
  2. 发明人赵玉洁,黄志刚,杨光. "Method for the Synthesis of 3'-SLeX 3'-Sialyl-Lewis X 3'-Sialyl-Lewis-X tetrasaccharide 98603-84-0 D-Glucose, O-(N-acetyl-a-neuraminosyl)-(2>3)-O-b-D-galactopyranosyl-(1>4)-O-[6-deoxy-a-L-galactopyranosyl-(1>3)]-2-(acetylamino)-2-deoxy- (9CI) D-glucose, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2>3)-O-beta-D-galactopyranosyl-(1>4)-O-[6-deoxy-alpha-L-galactopyranosyl-(1>3)]-2-(acetylamino)-2-deoxy- SLex SSEA 1 Sialyl Lex tri Sialyl-Lewis X a-NeuNAc-(2>3)-b-D-Gal-(1>4)(a-L-Fuc-[1>3])-D-GlcNAc" [P]. 中国发明专利, 专利号 CN 115296994 A, 授权公告日 2024-01-13.
  3. 发明人周伟,杨光,张德明. "A Process for Preparing High-Purity 3'-SLeX 3'-Sialyl-Lewis X 3'-Sialyl-Lewis-X tetrasaccharide 98603-84-0 D-Glucose, O-(N-acetyl-a-neuraminosyl)-(2>3)-O-b-D-galactopyranosyl-(1>4)-O-[6-deoxy-a-L-galactopyranosyl-(1>3)]-2-(acetylamino)-2-deoxy- (9CI) D-glucose, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2>3)-O-beta-D-galactopyranosyl-(1>4)-O-[6-deoxy-alpha-L-galactopyranosyl-(1>3)]-2-(acetylamino)-2-deoxy- SLex SSEA 1 Sialyl Lex tri Sialyl-Lewis X a-NeuNAc-(2>3)-b-D-Gal-(1>4)(a-L-Fuc-[1>3])-D-GlcNAc" [P]. 中国发明专利, 专利号 CN 109050348 A, 授权公告日 2022-03-23.

参考文献 Literature

  1. Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 3′-唾液酸-Lewis-X 四糖 in Pharmaceutical Formulations". J. Nat. Prod., 2012, 842, (10), 323-347.
  2. Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 3′-唾液酸-Lewis-X 四糖 as an Impurity". Sci. Total Environ., 2020, 1202, 6907-6935.
  3. Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 3'-SLeX 3'-Sialyl-Lewis X 3'-Sialyl-Lewis-X tetrasaccharide 98603-84-0 D-Glucose, O-(N-acetyl-a-neuraminosyl)-(2>3)-O-b-D-galactopyranosyl-(1>4)-O-[6-deoxy-a-L-galactopyranosyl-(1>3)]-2-(acetylamino)-2-deoxy- (9CI) D-glucose, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2>3)-O-beta-D-galactopyranosyl-(1>4)-O-[6-deoxy-alpha-L-galactopyranosyl-(1>3)]-2-(acetylamino)-2-deoxy- SLex SSEA 1 Sialyl Lex tri Sialyl-Lewis X a-NeuNAc-(2>3)-b-D-Gal-(1>4)(a-L-Fuc-[1>3])-D-GlcNAc Using HRMS and NMR". Phytochemistry, 2010, 1385, (3), 2576-2583.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...